ISSN 1674-3865  CN 21-1569/R
主管:国家卫生健康委员会
主办:中国医师协会
   辽宁省基础医学研究所
   辽宁中医药大学附属医院

中国中西医结合儿科学 ›› 2020, Vol. 12 ›› Issue (5): 421-425.doi: 10.3969/j.issn.1674-3865.2020.05.015

• 临床研究 • 上一篇    下一篇

19例儿童特发性肺含铁血黄素沉着症临床分析

卓裕霏,陈艳萍   

  1. 410000 长沙,湖南省儿童医院呼吸内科
  • 出版日期:2020-10-25 发布日期:2020-11-28
  • 通讯作者: 陈艳萍,E-mail:hnchengyanping@163.com
  • 作者简介:卓裕霏(1986-),女,医学硕士,主治医师。研究方向:儿童间质性肺疾病、过敏性疾病的诊治

Clinical analysis of 19 children with idiopathic pulmonary hemosiderosis

  • Online:2020-10-25 Published:2020-11-28

摘要: 目的 提高对特发性肺含铁血黄素沉着症的诊断治疗水平。
方法 分析2013年1月至2019年10月共19例诊断为特发性肺含铁血黄素沉着症患儿的临床资料。
结果 7例单用激素治疗的患儿中3例无复发,另外4例患儿在激素减量过程中复发。7例激素联合硫唑嘌呤治疗的患儿在单用激素期间病情反复发作,其中5例患儿在加用硫唑嘌呤后暂无复发(其中1例硫唑嘌呤仅使用1个月家长自行停用),2例患儿在加用硫唑嘌呤后各复发1次。另外有3例患儿单用激素治疗期间病情反复发作,加用硫唑嘌呤后有2例因粒细胞明显减少而停用,1例因严重的呕吐腹泻反应而停用,3例均改用激素联合羟氯喹治疗,加用羟氯喹后患儿病情复发次数减少,副作用少。最后两例患儿其中1例在确诊IPH 1年后出现游走性关节疼痛症状,后确诊为幼年特发性关节炎以及干燥综合征;治疗上采用激素联合甲氨蝶呤治疗,病情控制可,复发次数减少;另1例患儿因合并血尿及蛋白尿诊断肾炎综合征,采用激素联合他克莫司治疗1年,仍有咯血及血尿蛋白尿发作,后于外院改用激素联合来氟米特治疗半年余,患儿无咯血发作,无血尿蛋白尿发作。
结论 对于诊断为IPH的患儿单用激素治疗或激素联合硫唑嘌呤治疗效果不佳或因副作用不能耐受时,可考虑使用激素联合羟氯喹治疗效果尚可

关键词: 肺含铁血黄素沉着症, 激素, 硫唑嘌呤, 羟氯喹, 儿童

Abstract: Objective  To increase the diagnosis and treatment level of idiopathic pulmonary hemosiderosis.
Methods  The clinical data of 19 children diagnosed with idiopathic pulmonary hemosiderosis from January 2013 to October 2019 were analyzed.
Results  Among the seven cases treated with hormone alone, three cases had no relapse, and the other four cases relapsed during hormone reduction. Seven cases of children treated with hormone combined with azathioprine relapsed repeatedly during the period of hormone treatment alone, five of which had no relapse after adding azathioprine (in 1 case azathioprine was used for only one month, and the parents stopped using azathioprine by themselves), and two cases relapsed once after adding azathioprine. In addition, there were three cases of repeated attacks during hormone therapy alone, and then azathioprine was used, but in two cases it was stopped because of the obvious decrease of granulocytes, and in one case it was stopped because of the serious vomiting and diarrhea reaction; the three cases were all treated with hormone combined with hydroxychloroquine, and the number of relapses and side effects were reduced after adding hydroxychloroquine. In the remaining two cases, one patient was diagnosed with juvenile idiopathic arthritis and Sjogren's syndrome one year after the diagnosis of IPH; in the treatment, hormone combined with methotrexate was used to control the disease and reduce the recurrence; the other patient was diagnosed with nephritis syndrome because of hematuria and proteinuria. He was treated with hormone combined with tacrolimus for one year. He still had hemoptysis and hematuria and proteinuria. After that, he was treated with hormone combined with leflunomide for more than half a year in another hospital. He had no attack of hemoptysis or hematuria or proteinuria.
Conclusion  For children diagnosed with IPH, if hormone therapy alone or hormone combined with azathioprine is not effective or if the patient 〖JP2〗can not tolerate side effects, hormone combined with hydroxychloroquine can be considered for treatment

Key words: Pulmonary hemosiderosis, Hormone, Azathioprine, Hydroxychloroquine, Children